Reducing nihilism in metastatic pancreatic ductal adenocarcinoma: Treatment, sequencing, and effects on survival outcomes

BACKGROUND: Real‐world practice patterns, treatment sequencing, and outcomes in patients with metastatic pancreatic cancer remain unclear. Previous research indicates that the likelihood of patients with metastatic pancreatic cancer receiving or continuing cancer‐directed therapy is low—a phenomenon...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Reilly, Eileen M., Cockrum, Paul, Surinach, Andy, Wu, Zheng, Dillon, Allison, Yu, Kenneth H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666752/
https://www.ncbi.nlm.nih.gov/pubmed/32997898
http://dx.doi.org/10.1002/cam4.3477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666752/
https://www.ncbi.nlm.nih.gov/pubmed/32997898
http://dx.doi.org/10.1002/cam4.3477

Ejemplares similares